Enhancing osteoporosis treatment: emerging roles of engineered exosomes in bone regeneration and repair
Authors:
Open Access
- 29 January 2026
- journal article
- review article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 24 (1)
Abstract
Osteoporosis, a prevalent metabolic bone disease, is characterized by reduced bone density and an increased risk of fractures. The primary challenge in treKeywords
This publication has 199 references indexed in Scilit:
- Microfluidic Devices for Manufacture of Therapeutic Extracellular Vesicles: Advances and OpportunitiesJournal of Extracellular Vesicles, 2025
- Injectable Microgels with Hybrid Exosomes of Chondrocyte‐Targeted FGF18 Gene‐Editing and Self‐Renewable Lubrication for Osteoarthritis TherapyAdvanced Materials, 2024
- Anabolic and Antiresorptive Osteoporosis Treatment: Trends, Costs, and Sequence in a Commercially Insured Population, 2003–2021JBMR Plus, 2023
- M1 macrophage‐derived exosomes aggravate bone loss in postmenopausal osteoporosis via a microRNA‐98/DUSP1/JNK axisCell Biology International, 2021
- Cover Feature: Polydopamine‐Mediated Surface Functionalization of Exosomes (ChemNanoMat 6/2021)Chemnanomat, 2021
- Tumor Exosomes Reprogrammed by Low pH Are Efficient Targeting Vehicles for Smart Drug Delivery and Personalized Therapy against their Homologous TumorAdvanced Science, 2021
- Bisphosphonates for Postmenopausal OsteoporosisJAMA, 2021
- Exosome‐Guided Phenotypic Switch of M1 to M2 Macrophages for Cutaneous Wound HealingAdvanced Science, 2019
- MiR-503 Regulates Osteoclastogenesis via Targeting RANKJournal of Bone and Mineral Research, 2013
- Dendritic cells: Understanding immunogenicityEuropean Journal of Immunology, 2007